Mathurin Cyrille Tejiokem

Author

Also Known As

A. Soufi, Céline Nkenfou, M Tejiokem, M. C. Tejiokem, M. Tejiokem, M.C. Tejiokem, M.C. Téjiokem, MATHURIN CYRILLE TEJIOKEM, Mathurin C Téjiokem, Mathurin C. Tejiokem

109

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Centre Pasteur du Cameroun Inserm Institut de Recherche pour le Développement Centre International De Reference Chantal Biya Assistance Publique – Hôpitaux de Paris

About

Mathurin Cyrille Tejiokem is an author at Centre Pasteur du Cameroun specializing in medicine, epidemiology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	10	379
2	Epidemiology	7	7	310
3	Public Health	3	3	120
4	Global Health	2	2	94
5	Health Sciences	1	1	16

Mathurin Cyrille Tejiokem

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Performance of Xpert MTB/RIF and Alternative Specimen Collection Methods for the Diagnosis of Tuberculosis in HIV-Infected Children Olivier Marcy, Ung Vibol, Sophie Goyet, Clinical Infectious Diseases	2016	79
Fighting rabies in Africa: The Africa Rabies Expert Bureau (AfroREB) Betty Dodet, Edgard Adjogoua, A.R. Aguèmon, Vaccine VaccinationAfrican ConflictEmerging Infectious DiseasesGlobal HealthAnimal Protection	2008	78
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial Milagritos D. Tapia, Samba O. Sow, B Ndiaye, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccine DevelopmentImmunologyEbola Vaccine	2020	75
Feasibility of Early Infant Diagnosis of HIV in Resource-Limited Settings: The ANRS 12140-PEDIACAM Study in Cameroon Mathurin Cyrille Tejiokem, Albert Faye, Calixte Ida Penda, PLoS ONE	2011	65
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial Milagritos D. Tapia, Samba O. Sow, Khardiata Diallo Mbaye, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccine DevelopmentImmunologyEbola Vaccine	2020	63
Factors Associated with Death during Tuberculosis Treatment of Patients Co-Infected with HIV at the Yaoundé Central Hospital, Cameroon: An 8-Year Hospital-Based Retrospective Cohort Study (2006–2013) Ako A. Agbor, Jean Joël Bigna, Serges Clotaire Billong, PLoS ONE	2014	52
A low proportion of HBeAg among HBsAg-positive pregnant women with known HIV status could suggest low perinatal transmission of HBV in Cameroon Anfumbom Kfutwah, Mathurin Cyrille Tejiokem, Richard Njouom Virology Journal	2012	50
HIV-Infected Children Living in Central Africa Have Low Persistence of Antibodies to Vaccines Used in the Expanded Program on Immunization Mathurin Cyrille Tejiokem, I. Gouandjika, Lydie Béniguel, PLoS ONE	2007	48
A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis Olivier Marcy, Laurence Borand, Ung Vibol, PEDIATRICS	2019	44
Effect of Two or Six Doses 800 mg of Albendazole Every Two Months on Loa loa Microfilaraemia: A Double Blind, Randomized, Placebo-Controlled Trial Joseph Kamgno, Patrick Nguipdop‐Djomo, Racéline Kamkumo Gounoue, PLoS neglected tropical diseases	2016	43

Page 1